MDT

Medtronic
D

MDT

Arincen70/100B
101.820
USD
-3.03
(-2.89%)
Pre Open
Last updated: · Delayed 15 min
Fair value103.28Plus-1%77Price 101.82180
Q2 FY2027 · Earnings report
EPS estimate 1.33Revenue estimate 9.48B
OverviewFinancialsNewsForecastEarningsDividendsCompany

Medtronic debt to equity ratio

Medtronic's debt to equity ratio is 0.56: total debt of 28.15B USD against shareholders' equity of 50.23B USD.

Today
0.56
Average, 5 years
0.53
Low, 5 years
0.44
High, 5 years
0.60

Debt to equity = total debt ÷ shareholders' equity = 28.15B ÷ 50.23B = 0.56

Debt to equity
Total debt
Shareholders' equity

Total debt over shareholders' equity at each quarter end.

Debt to equity by year and by quarter

Fiscal yearPeriod endingDebt to equityTotal debtShareholders' equity
Today0.5628.15B50.23B
FY202624 Apr 20260.5727.96B49.46B
FY202525 Apr 20250.5928.52B48.02B
FY202426 Apr 20240.5025.02B50.21B
FY202328 Apr 20230.4724.36B51.48B
FY202229 Apr 20220.4624.11B52.55B
FY202130 Apr 20210.5126.39B51.43B
FY202030 Apr 20200.4924.80B50.74B
FY201926 Apr 20190.5125.32B50.09B
FY201827 Apr 20180.5125.76B50.72B
FY201728 Apr 20170.6633.40B50.29B
FY201629 Apr 20160.6031.01B51.83B
FY201530 Apr 20150.6836.11B53.23B
FY201425 Apr 20140.6111.87B19.44B
FY201330 Apr 20130.5710.62B18.67B
FY201230 Apr 20120.6110.47B17.11B
FY201130 Apr 20110.609.66B15.97B
FY201030 Apr 20100.659.52B14.63B
FY200930 Apr 20090.536.78B12.85B
FY200830 Apr 20080.606.96B11.54B
FY200730 Apr 20070.556.09B10.98B
FY200630 Apr 20060.847.92B9.38B
FY200530 Apr 20050.232.45B10.45B
FY200430 Apr 20040.262.36B9.08B
FY200330 Apr 20030.302.37B7.91B
FY200230 Apr 20020.392.53B6.43B
FY200130 Apr 20010.03158.70M5.51B
FY200030 Apr 20000.07332.10M4.49B
FY199930 Apr 19990.07262.60M3.77B
FY199830 Apr 19980.09192.00M2.04B
FY199730 Apr 19970.07120.40M1.75B
FY199630 Apr 19960.0475.80M1.79B
FY199530 Apr 19950.0447.70M1.34B
FY199430 Apr 19940.0778.40M1.05B
FY199330 Apr 19930.12102.80M841.50M
FY199230 Apr 19920.1189.20M796.50M
FY199130 Apr 19910.1498.80M683.20M
FY199030 Apr 19900.1794.30M541.00M
FY198930 Apr 19890.1779.90M473.60M
FY198830 Apr 19880.1559.90M395.90M
FY198730 Apr 19870.1037.40M387.00M
FY198630 Apr 19860.1346.60M348.70M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,ROE (return on equity),Current ratio,All ratios

Common questions about Medtronic's debt to equity

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.